However, IDH2 mutant (R140Q) AML cells surprisingly exhibited resistance to DM-αKG treatment (Fig. 5d; Additional file 3: Fig. S4c, d), indicating a major difference between the leukemia cells with wt-IDH2 and those with mutated IDH2. This evidence concerns the gene IDH2 and acute myeloid leukemia.